{"nct_id":"NCT00206726","title":"Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)","status":"COMPLETED","status_verified_date":"2016-07","start_date":"2005-05","start_date_type":null,"primary_completion_date":"2008-04","primary_completion_date_type":"ACTUAL","completion_date":"2008-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}